Loading
Latest filing published 06 Mar 2026 for Bayer Aktiengesellschaft, €100k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Prof. Dr. Norbert Winkeljohann in Bayer Aktiengesellschaft, where the filings describe the role as board member. The record holds 2 filings, all for trades on 5 March 2026.
Every open-market trade on record is a purchase: 2 purchases worth €200k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 6 March 2026: an open-market purchase of €100k, in Bayer Aktiengesellschaft. Source: insider filings from BaFin. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations